OMEROS CORP Shareholders' Equity
OMEROS CORP (OMER) had Shareholders' Equity of -$51.35 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent -$51.35M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$63.33M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$121.23M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$220.48M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$51.35M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$63.33M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | -$121.23M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$220.48M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$228.69M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | -$213.55M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | -$182.61M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | -$154.17M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$124.60M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | -$71.33M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | -$24.98M 10-K · filed 2026-03-31 | |
| 2023-09-30 | -$13.95M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $20.51M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $54.94M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $85.68M 10-K · filed 2026-03-31 | |
| 2022-09-30 | -$46.31M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$32.70M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | -$4.92M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $23.78M 10-K · filed 2025-03-31 | |
| 2021-09-30 | -$262.70M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$246.30M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | -$221.96M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | -$120.75M 10-K · filed 2024-04-01 | |
| 2020-09-30 | -$87.33M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$161.27M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | -$131.86M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | -$109.02M 10-K · filed 2023-03-13 | |
| 2019-09-30 | -$139.91M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$130.27M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | -$121.02M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | -$100.16M 10-K · filed 2022-03-01 | |
| 2018-09-30 | -$89.00M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$56.30M 10-Q · filed 2019-11-12 | -$56.30M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$29.21M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | -$2.81M 10-K · filed 2021-03-01 | |
| 2017-09-30 | $9.21M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$54.85M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$48.11M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$37.45M 10-K · filed 2020-03-02 | |
| 2016-09-30 | -$22.77M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$48.99M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$40.74M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$26.23M 10-K · filed 2019-03-01 | |
| 2015-09-30 | -$9.00M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $7.93M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $21.85M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$42.65M 10-K · filed 2018-03-01 | |
| 2014-09-30 | -$26.59M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$10.61M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $5.21M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$18.38M 10-K · filed 2017-03-16 | |
| 2013-09-30 | -$23.89M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$12.26M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$15.86M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$6.53M 10-K · filed 2016-03-15 | |
| 2012-09-30 | -$820.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$20.54M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | -$12.68M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$5.55M 10-K · filed 2015-03-16 | |
| 2011-09-30 | $4.08M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $10.02M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $20.47M 10-K · filed 2014-03-13 | |
| 2009-12-31 | $43.15M 10-K · filed 2013-03-18 | |
| 2008-12-31 | -$91.17M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |